COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,384 Articles (22,816 medRxiv, 8,568 bioRxiv)

Most recent first Previous |  Page 476: Articles 4751-4760  | Next

Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants
Pavan, M. F., Bok, M., Betanzos San Juan, R., Malito, J. P., Marcoppido, G. A., Franco, D. R., Militello, D. A., Schammas, J. M., Bari, S., Stone, W. B., Lopez, K., Porier, D., Muller, J., Auguste, A. J., Yuan, L., Wigdorovitz, A., Parreno, V., Ibanez, L. I.
10.1101/2023.03.14.532528 — Posted: 2023-03-14
Persistence of SARS-CoV-2 and its surrogate, bacteriophage Phi6, on surfaces and in water
Pitol, A. K., Venkatesan, S., Hughes, G.
10.1101/2023.03.14.532590 — Posted: 2023-03-14
Deep physico-chemical characterization of individual serum antibody responses against SARS-CoV-2 RBD using a dual titration microspot assay
Kovacs, A., Herincs, Z., Papp, K., Kaczmarek, J. Z., Larsen, D. N., Stage, P., Bereczki, L., Ujhelyi, E., Pfeil, T., Prechl, J.
10.1101/2023.03.14.532012 — Posted: 2023-03-14
Murine Alveolar Macrophages Rapidly Accumulate Intranasally Administered SARS-CoV-2 Spike Protein leading to Neutrophil Recruitment and Damage
Park, C., Hwang, I.-Y., Yan, S. L.-S., Vimonpatranon, S., Wei, D., Van Ryk, D., Cicala, C., Arthos, J., Kehrl, J. H.
10.1101/2023.03.13.532446 — Posted: 2023-03-14
How long is the long COVID? a retrospective analysis of football players in two major European Championships.
Miccinilli, S., Bravi, M., Conti, G., Bressi, F., Sterzi, S., Santacaterina, F., Ciccozzi, M.
10.1101/2023.03.11.23287138 — Posted: 2023-03-14
The cost of primary care consultations associated with long COVID in non-hospitalised patients: a retrospective cohort study using UK primary care data
Tufts, J., T Zemedikun, D., Subramanian, A., Guan, N., Gokhale, K., Myles, P., Williams, T., Marshall, T., Calvert, M., Matthews, K., Nirantharakumar, K., Jackson, L., Haroon, S.
10.1101/2023.03.12.23287049 — Posted: 2023-03-14
SARS-CoV-2 N-protein induces the formation of composite α-synuclein/N-protein fibrils that transform into a strain of α-synuclein fibrils
Semerdzhiev, S. A., Segers-Nolten, I., Schoot, P. v. d., Blum, C., Claessens, M. M. A. E.
10.1101/2023.03.13.532385 — Posted: 2023-03-13
Inhibition of SARS-CoV-2 3CLpro in vitro by chemically modified tyrosinase from Agaricus bisporus
Aguilera, D., Palomo, J. M.
10.1101/2023.03.13.532357 — Posted: 2023-03-13
Development of monoclonal antibody-based blocking ELISA for detecting SARS-CoV-2 exposure in animals
Yuan, F., Chen, C., Covaleda, L. M., Martins, M., Reinhart, J. M., Sullivan, D. R., Diel, D., Fang, Y.
10.1101/2023.03.11.532204 — Posted: 2023-03-13
In vitro comparison of SARS-CoV-2 variants
Phadke, K. S., Higdon, N. B. A., Bellaire, B. H.
10.1101/2023.03.11.532212 — Posted: 2023-03-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).